Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EPHX1 | P07099 | 1/20 | 0.52 |
| ▸ | ACHE | P22303 | 14/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.50 |
| ▸ | ATM | Q13315 | 1/20 | 0.47 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.45 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.44 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.44 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.44 |
| ▸ | HPGD | P15428 | 1/20 | 0.44 |
| ▸ | TSHR | P16473 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16824229 | 0.87 | EPHX1 (0.59) | EPHX1ACHEALDH1A1ATML3MBTL1 | |
| SCHEMBL473161 | 0.84 | EPHX1 (0.53) | EPHX1ACHEALDH1A1ATM | |
| SCHEMBL4736240 | 0.82 | EPHX1 (0.56) | EPHX1ACHEALDH1A1 | |
| SCHEMBL473278 | 0.82 | EPHX1 (0.56) | EPHX1ACHEALDH1A1 | |
| SCHEMBL28460826 | 0.81 | EPHX1 (0.46) | EPHX1ACHEALDH1A1ATML3MBTL1 | |
| SCHEMBL288938 | 0.81 | EPHX1 (0.59) | EPHX1ACHEALDH1A1ATML3MBTL1 | |
| SCHEMBL11650927 | 0.81 | EPHX1 (0.53) | EPHX1ACHEALDH1A1ATML3MBTL1 | |
| SCHEMBL7402018 | 0.80 | ACHE (0.47) | EPHX1ACHEALDH1A1 | |
| SCHEMBL5763848 | 0.79 | ACHE (0.53) | EPHX1ACHEALDH1A1ATML3MBTL1 | |
| SCHEMBL28079899 | 0.79 | EPHX1 (0.61) | EPHX1ACHE |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2432760-A1 | BRIDGED SPIRO [2.4]HEPTANE DERIVATIVES AS ALX RECEPTOR AND/OR FPRL2 AGONISTS | Actelion Pharmaceuticals Ltd. (CH) | 2012-03-28 | — | — | EP | disclosed |
| WO-2010134014-A1 | BRIDGED SPIRO [2.4] HEPTANE DERIVATIVES AS ALX RECEPTOR AND/OR FPRL2 AGONISTS | ACTELION PHARMACEUTICALS LTD (CH) | 2010-11-25 | — | — | WO | disclosed |
| EP-1689789-A2 | NOVEL CYCLODEXTRIN DIMERS AND DERIVATIVES THEREOF, METHODS FOR PREPARING THEM AND THEIR USE, IN PARTICULAR, FOR SOLUBILIZING PHARMACOLOGICALLY ACTIVE SUBSTANCES | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS) (FR) | 2006-08-16 | — | — | EP | disclosed |
| WO-2005054303-A2 | CYCLODEXTRIN DIMERS AND DERIVATIVES THEREOF, METHODS FOR PREPARING THEM AND THEIR USE, IN PARTICULAR, FOR SOLUBILIZING PHARMACOLOGICALLY ACTIVE SUBSTANCES | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) | 2005-06-16 | — | — | WO | disclosed |
| WO-2004101589-A1 | NOVEL 14 AND 15 MEMBERED-RING COMPOUNDS | GLAXO GROUP LIMITED (GB) | 2004-11-25 | — | — | WO | disclosed |
| WO-1997043289-A1 | LARGE SYNTHETIC COMPOUNDS BASED ON ELECTRON DONOR AND ELECTRON ACCEPTOR INTERACTIONS | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 1997-11-20 | — | — | WO | disclosed |